title: Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA Study.
abstract: BACKGROUND
  The hypothesis of carotenoids having a preventive role in cognitive impairment is suggested by their antioxidant properties.
  
  
  METHODS
  We examined, in a cross-sectional analysis, the relationship between cognitive performance (assessed by the Mini-Mental State Examination, Trail Making Test Part B, Digit Symbol Substitution, Finger Tapping Test, and Word Fluency Test) and different plasma carotenoids (lutein, zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, and trans-beta-carotene and cis-beta-carotene) in a healthy elderly population (the EVA,"Etude du Vieillissement Artériel," study; n = 589, age = 73.5 +/- 3 years).
  
  
  RESULTS
  Logistic regression showed that participants with the lowest cognitive functioning (<25th percentile) had a higher probability of having low levels of specific plasma carotenoids (<1st quartile): lycopene and zeaxanthin. For zeaxanthin, odds ratios (ORs) were as follows: OR(DSS) = 1.97 (95% confidence interval [CI] = 1.21-3.20), OR(FTT) = 1.70 (CI = 1.05-2.74), and OR(WFT) = 1.82 (CI = 1.08-3.07); for lycopene, OR(DSS) = 1.93 (CI = 1.20-3.12) and OR(TMTB) = 1.64 (CI = 1.04-2.59).
  
  
  CONCLUSIONS
  Even if it is not possible to affirm if these low levels of carotenoids precede or are the consequence of cognitive impairment, our results suggest that low carotenoid levels could play a role in cognitive impairment. The biological significance of our findings needs further research.
authors: INSERM U888, Hôpital La Colombière, 39 Avenue Charles Flahault, BP 34493, 34093 Montpellier, Cedex 5, France. akbaraly@montp.inserm.fr
authors: N Tasnime
authors: NT
authors: Akbaraly
authors: Henri
authors: H
authors: Faure
authors: Veronique
authors: V
authors: Gourlet
authors: Alain
authors: A
authors: Favier
authors: Claudine
authors: C
authors: Berr
mesh_terms: D000368:Aged; D000975:Antioxidants / Q000032:analysis*; D002338:Carotenoids / Q000097:blood*; D003071:Cognition / Q000502:physiology*; D003072:Cognition Disorders / Q000097:blood; D003430:Cross-Sectional Studies; D065366:Cryptoxanthins; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D014975:Lutein / Q000097:blood; D000077276:Lycopene; D008297:Male; D008609:Mental Status Schedule; D009048:Motor Skills; D012680:Sensitivity and Specificity; D013237:Stereoisomerism; D014145:Trail Making Test; D014705:Verbal Behavior; D024341:Xanthophylls / Q000097:blood; D065146:Zeaxanthins; D019207:beta Carotene / Q000097:blood
chemical_list: D000975:Antioxidants; D065366:Cryptoxanthins; D024341:Xanthophylls; D065146:Zeaxanthins; D019207:beta Carotene; D002338:Carotenoids; C041635:alpha-carotene; D000077276:Lycopene; D014975:Lutein